UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED ~~September~~March 3031, ~~2022~~2023.

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM __________________ TO __________________

Commission File No. 333-141875

IGEN Networks Corp.

(Exact name of registrant as specified in its charter)

Nevada

20-5879021

(State or Other Jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

~~31722~~28375 ~~Casino~~Rostrata ~~Drive,~~Ave. ~~Suite C~~ Lake Elsinore, CA ~~92530~~92532

(Address of principal executive offices) (Zip Code)

1-855-912-5378

(Registrant’s telephone number including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically ~~and posted on its corporate Web site, if any,~~ every Interactive Data File required to be submitted ~~and posted~~ pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit ~~and post~~ such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer: ☐ Accelerated filer: ☐ Non-accelerated filer: ☒ Smaller reporting company: ☒ (Do not check if a smaller reporting company) Emerging growth company: ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The number of shares of the registrant’s common stock issued and outstanding as of ~~October~~June 275, ~~2022~~2023 is 12,~~712~~222,~~178~~437,~~280~~202.

TABLE OF CONTENTS

		Page
PART I
ITEM 1.	FINANCIAL STATEMENTS	F-1 to F-1716
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	34
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	67
ITEM 4.	CONTROLS AND PROCEDURES	67
PART II
ITEM 1.	LEGAL PROCEEDINGS	78
ITEM 1A.	RISK FACTORS	78
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	78
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	78
ITEM 4.	MINE SAFETY DISCLOSURES	78
ITEM 5.	OTHER INFORMATION	78
ITEM 6.	EXHIBITS	89

Table of Contents

Part I

FINANCIAL INFORMATION

Item 1. Financial Statements

The Company’s unaudited condensed consolidated interim financial statements for the three ~~and nine~~ -month ~~periods~~period ended ~~September~~March 3031, ~~2022~~2023 are included herewith.

IGEN NETWORKS CORP.

Condensed Consolidated Interim Financial Statements

For the Three ~~and Nine~~ Months Ended ~~September~~March 3031, ~~2022~~2023

(Unaudited - Expressed in U.S. Dollars)

F-1

Table of Contents

IGEN NETWORKS CORP.

Condensed Consolidated Interim Balance Sheets

(Expressed in U.S. dollars)~~(Unaudited)~~

	September 30,2022			December 31,2021
	March 31,2023			December 31,2022
	(unaudited)
Assets
Current Assets
Cash	$	~~83,569~~-		$	~~64,429~~-
Accounts and other receivables, net		~~10,483~~632			3821,~~754~~902
Inventory		4833,~~147~~866			7130,~~183~~141
Total Current Assets		~~142~~34,~~199~~498			~~174~~52,~~366~~043
Operating lease asset, net		5946,~~068~~826			7653,~~230~~017
Security deposits		5,722			5,722
Goodwill		505,508			505,508
Total Assets	$	~~712~~592,~~497~~554		$	~~761~~616,~~826~~290
Liabilities and Stockholders’ Deficit
Current Liabilities
Accounts payable and accrued liabilities	$	~~378~~359,~~300~~826		$	~~678~~360,~~347~~227
Current portion of deferred revenue, net of contract assets		8177,~~380~~495			6581,~~715~~066
Notes payable, current portion		~~423~~635,~~297~~230			~~114~~596,~~338~~746
Convertible debentures, current portion, net of discount of $0 and $30,586, respectively		37,000			89,064
Convertible debentures		37,000			37,000
Derivative liabilities		~~103~~88,~~290~~462			~~136~~111,~~902~~010
Total Current Liabilities		1,~~023~~198,~~267~~013			1,~~084~~186,~~366~~049
Notes payable, net of current portion		~~265~~162,~~502~~142			~~152~~160,~~147~~736
Operating lease liability, net of current portion		3419,~~716~~250			5527,~~211~~098
Deferred revenue, net of current portion and contract assets		8666,~~061~~143			7981,~~770~~632
Total Liabilities		1,~~409~~445,~~546~~548			1,~~371~~455,~~494~~515
Commitment and contingencies
Redeemable convertible preferred stock - Series A:
Redeemable convertible preferred stock - Series A: Authorized – 1,250,000 shares with $0.001 par value, 194,500 shares and 214,500 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively, net of discount of $79,179 and $59,954, respectively, aggregate liquidation preference of $199,741 and $218,222 as of March 31, 2023 and December 31, 2022, respectively		103,059			138,429
Authorized – 1,250,000 shares with $0.001 par value, 267,125 shares and 199,375 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively, net of discount of $73,053 and $101,317, respectively, aggregate liquidation preference of $194,782 and $203,463 as of September 30, 2022 and December 31, 2021, respectively		160,063			84,022
Stockholders’ Deficit
Series B preferred stock: Authorized - 5,000,000 shares with $0.001 par value issued and outstanding – 3,750,000 and 5,000,000, as of September 30, 2022 and December 31, 2021, respectively		3,750			5,000
Series B preferred stock: Authorized - 5,000,000 shares with $0.001 par value issued and outstanding – 3,750,000, as of March 31, 2023 and December 31, 2022		3,750			3,750
Common stock: Authorized - 1,890,000,000 shares with $0.001 par value issued and outstanding – 1,570,693,032 and 1,476,869,532 shares, as of September 30, 2022 and December 31, 2021, respectively		1,687,287			1,476,870
Common stock: Authorized – 2,900,000,000 shares with $0.001 par value issued and outstanding – 2,034,481,764 and 1,890,261,047 shares, as of March 31, 2023 and December 31, 2022, respectively		2,034,483			1,890,262
Additional paid-in capital		17,~~193~~348,~~648~~124			1617,~~900~~298,~~962~~474
Accumulated Deficit		(19,741,797	)		(19,076,522	)
Accumulated deficit		(20,342,410	)		(20,170,140	)
Total Stockholders’ Deficit		(~~857~~956,~~112~~053	)		(~~693~~977,~~690~~654	)
Total Liabilities and Stockholders’ Deficit	$	~~712~~592,~~497~~554		$	~~761~~616,~~826~~290

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

F-2

Table of Contents

IGEN NETWORKS CORP.

Condensed Consolidated Interim Statements of Operations

(Unaudited - Expressed in U.S. dollars)

	Three Months EndedSeptember 30,						Nine Months EndedSeptember 30,
	Three Months EndedMarch 31,
	2022			2021			2022			2021
	2023			2022
Revenues:
Sales, services	$	~~131~~47,~~575~~216		$	5846,~~539~~260		$	~~269,811~~		$	~~220,968~~
Sales, other		-			-			-			-
Total Revenues		~~131~~47,~~575~~216			5846,~~539~~260			~~268,811~~			~~220,968~~
Cost of goods sold		~~161~~27,~~249~~250			4914,~~556~~495			~~267,844~~			~~164,270~~
Gross Profit (Loss)		(29,674	)		8,983			1,967			56,698
Gross Profit		19,966			31,765
Expenses:
Selling, general and administrative		~~135~~86,~~538~~300			~~153~~38,~~155~~214			~~322,585~~			~~384,144~~
Management and consulting fees		6913,~~094~~250			4367,~~322~~796			~~156,558~~			~~137,478~~
Payroll and related		~~120~~35,~~528~~037			71109,~~523~~799			~~289,692~~			~~217,825~~
Stock-based compensation expense		-			-			-			291,374
Stock-based director expense		-			-
Total Expenses		~~325~~134,~~160~~587			~~268~~215,~~000~~809			~~768,835~~			~~1,030,821~~
Loss Before Other Income (Expense)		(~~354~~114,~~834~~621	)		(~~259~~184,~~017~~044	)		~~(766,868~~	)		~~(974,123~~	)
Other Income (Expense):
Accretion of discounts on convertible debentures		-			(3125,~~106~~410	)		~~(35,201~~	)		~~(103,035~~	)
Change in fair value of derivative liabilities		~~(47~~44,~~427~~488	)		3339,~~001~~574			~~8,558~~			~~156,503~~
Gain (loss) on extinguishment of debt		70,588			-			342,523			-
Interest expense		(46,676	)		(16,227	)
Interest expense		(29,417	)		(5,244	)		(85,627	)		(20,196	)
Total Other Income (Expense), net		(2,188	)		(2,063	)
Total Other Income (Expense), net		(6,256	)		(3,349	)		230,253			33,272
Net loss before provision for income taxes		(116,809	)		(186,107	)
Net Income (Loss)		(361,090	)		(262,366	)		(536,615	)		(940,851	)
Provision for income taxes		-			-
Accrued and deemed dividends on redeemable convertible preferred stock		(126,098	)		(169,740	)		(128,660	)		(371,926	)
Net Loss		(116,809	)		(186,107	)
Net loss attributable to common stockholders	$	(487,188	)	$	(432,106	)	$	(665,275	)	$	(1,312,777	)
Deemed dividend on preferred stock		(55,461	)		(96,330	)
Basic and Diluted Loss per Common Share	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Net loss attributable to common stockholders	$	(172,270	)	$	(282,437	)
Weighted Average Number of Common Shares Outstanding		1,628,362,535			1,329,721,262			1,559,578,608			1,263,939,724
Basic and Diluted Loss per Common Share	$	(0.00	)		(0.00	)
Weighted Average Number of Common Shares Outstanding		1,933,729,474			1,500,021,665

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

F-3

Table of Contents

IGEN NETWORKS CORP.

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit

(Unaudited - Expressed in U.S. dollars)

	Redeemable Series A																						Total
	Convertible						Series B										Additional						Stockholders’
	ConvertiblePreferred Stock						Series BPreferred Stock						Common Stock				AdditionalPaid In			Accumulated			Stockholders’ Equity
	Preferred Stock						Preferred Stock						Common Stock				Paid In			Accumulated			Equity
	Shares			Amount			Shares			Amount			Shares		Amount		Capital			Deficit			(Deficit)
Balance, December 31, 2021		199,375		$	84,022			5,000,000		$	5,000			1,476,869,532	$	1,476,870	$	16,900,962		$	(19,076,522	)	$	(693,690	)
Balance, December 31, 2022		214,500		$	138,429			3,750,000		$	3,750			1,890,261,047	$	1,890,262	$	17,298,474		$	(20,170,140	)	$	(977,654	)
Shares of Series A preferred stock issued for cash, net of costs and discounts		118,250			50,282			-			-					-		-			-			-
Shares of Series A preferred stock for cash, net of costs and discounts		59,125			-			-			-			-		-		-			(11,706	)		(11,706	)
Conversion of Series A preferred stock to common stock		(118,250	)		(59,844	)		-			-			37,377,063		37,377		130,750			(58,406	)		109,721
Conversion of Series A preferred shares to common stock		(79,125	)		(62,977	)		-			-			88,156,667		88,157		35,129			(16,148	)		107,138
Accrued dividends on Series A preferred stock		-			3727,~~924~~607			-			-			-		-		-			(3727,~~924~~607	)		(3727,~~924~~607	)
Shares of common stock for cashless exercise of warrants		-			-			-			-			19,560,705		19,561		(19,561	)		-			-
Shares of common stock issued for cash		-			-			-			-			34,064,050		34,064		(2,079	)		-			31,985
Shares of common stock issued for services		-			-			-			-			322,~~113~~000,~~005~~000		322,~~113~~000		1016,~~500~~600			-			1338,~~613~~600
Net loss		-			-			-			-			-		-		-			(~~186~~116,~~107~~809	)		(~~186~~116,~~107~~809	)
Balance, March 31, 2022		199,375		$	112,384			5,000,000		$	5,000			1,536,920,305	$	1,536,921	$	17,022,651		$	(19,358,959	)	$	(794,387	)
Balance, March 31, 2023		194,500		$	103,059			3,750,000		$	3,750			2,034,481,764	$	2,034,483	$	17,348,124		$	(20,342,410	)	$	(956,053	)
Shares of Series A preferred stock issued for cash, net of costs and discounts		112,750			56,065			-			-					-		-			-			-
Conversion of Series A preferred stock to common stock		(45,000	)		(38,204	)		-			-			21,272,727		21,273		45,382			(2,968	)		63,687
Accrued dividends on Series A preferred stock		-			26,800			-			-					-		-			(26,800	)		(26,800	)
Shares of common stock issued for equity line commitment		-			-			-			-			12,500,000		12,500		(12,500	)		-			-
Net income		-			-			-			-					-		-			10,582			10,582
Balance, June 30, 2022		267,125		$	157,045			5,000,000		$	5,000			1,570,693,032	$	1,570,694	$	17,055,533		$	(19,378,145	)	$	(746,918	)
Shares of Series A preferred stock issued for cash, net of costs and discounts		118,250			71,000			-			-					-		-			-			-
Conversion of Series A preferred stock to common stock		(136,115	)		(102,669	)		-			-			73,635,476		73,635		156,155			(33,447	)		196,343
Accrued dividends on Series A preferred stock		-			34,687			-			-					-		-			(34,687	)		(34,687	)
Shares of common stock issued for cash		-			-			-			-			42,957,989		42,958		46,282			-			89,240
Repurchase of Series B preferred stock		-			-			(1,250,000	)		(1,250	)		-		-		(64,322	)		65,572			-
Net loss		-			-			-			-					-		-			(361,090	)		(361,090	)
Balance, September 30, 2022		249,260		$	160,063			3,750,000		$	3,750			1,687,286,497	$	1,687,287	$	17,193,648		$	(19,741,797	)	$	(857,112	)

F-4 Table of Contents

	Redeemable Series A																				Total
	Convertible Preferred Stock						Series B Preferred Stock				Common Stock				Additional Paid In			Accumulated			Stockholders’ Equity
	Shares			Amount			Shares		Amount		Shares		Amount		Capital			Deficit			(Deficit)

Ba-lance, December 31, 2021		199,375		$	84,022			5,000,000	$	5,000		1,476,869,532	$	1,476,870	$	16,900,962		$	(19,076,522	)	$	(693,690	)

Shares of Series A preferred stock issued for cash, net of costs and discounts		118,250			50,282			-		-				-		-			-			-

Conversion of Series A preferred stock to common stock		(118,250	)		(59,844	)		-		-		37,377,063		37,377		130,750			(58,406	)		109,721

Accrued dividends on Series A preferred stock		-			37,924			-		-				-		-			(37,924	)		(37,924	)

Shares of common stock for cashless exercise of warrants		-			-			-		-		19,560,705		19,561		(19,561	)		-			-

Shares of common stock issued for services		-			-			-		-		3,113,005		3,113		10,500			-			13,613

Net loss		-			-			-		-				-		-			(186,107	)		(186,107	)

Balance, March 31, 2022		199,375		$	112,384			5,000,000	$	5,000		1,536,920,305	$	1,536,921	$	17,022,651		$	(19,358,959	)	$	(794,387	)

	Redeemable Series A																							Total
	Convertible						Series B								Additional									Stockholders’
	Preferred Stock						Preferred Stock				Common Stock				Paid In			Subscription			Accumulated			Equity
	Shares			Amount			Shares		Amount		Shares		Amount		Capital			Receivable			Deficit			(Deficit)
Balance, December 31, 2020		186,450		$	51,907			1,000,000	$	1,000		1,192,192,158	$	1,192,192	$	13,068,978		$	-		$	(15,185,187	)	$	(923,017	)
Shares of Series A preferred stock for cash, net of costs and discounts		139,700			10,723			-		-		-		-		-			-			(63,451	)		(63,451	)
Issuance of Series B preferred stock		-			-			500,000		500		-		-		277,947			-			-			278,447
Conversion of Series A preferred shares to common stock		(105,600	)		(49,323	)		-		-		14,181,071		14,181		173,634			-			(56,277	)		131,538
Accrued dividends on Series A preferred stock		-			21,733			-		-		-		-		-			-			(21,733	)		(21,733	)
Shares of common stock issued for cash		-			-			-		-		21,776,961		21,777		86,600			(51,822	)		-			56,555
Shares of common stock issued for accrued expenses		-			-			-		-		3,243,875		3,244		13,299			-			-			16,543
Net loss		-			-			-		-		-		-		-			-			(352,548	)		(352,548	)
Balance, March 31, 2021		220,550		$	35,040			1,500,000	$	1,500		1,231,394,065	$	1,231,394	$	13,620,458		$	(51,822	)	$	(15,679,196	)	$	(877,666	)
Collection of subscription receivable		-		$	-			-	$	-		-	$	-	$	-		$	51,822		$	-		$	51,822
Shares of Series A preferred stock for cash, net of costs and discounts		178,475			87,342			-		-		-		-		-			-			-
Conversion of debt to shares of common stock		-			-			-		-		1,780,825		1,781		16,829			-			-			18,610
Conversion of Series A preferred shares to common stock		(80,850	)		(57,812	)		-		-		13,561,935		13,562		101,238			-			(23,039	)		91,761
Accrued dividends on Series A preferred stock		-			37,686			-		-		-		-		-			-			(37,686	)		(37,686	)
Shares of common stock issued for cash		-			-			-		-		31,991,422		31,991		134,088			-			-			166,079
Shares of common stock issued for compensation		-			-			-		-		1,790,271		1,790		11,138			-			-			12,928
Net loss		-			-			-		-		-		-		-			-			(325,937	)		(325,937	)
Balance, June 30, 2021		318,175		$	102,256			1,500,000	$	1,500		1,280,518,518	$	1,280,518	$	13,883,751		$	-		$	(16,065,858	)	$	(900,089	)
Shares of common stock issued for equity line commitment fee		-		$	-			-	$	-		5,479,452	$	5,479	$	(5,479	)	$	-		$	-		$	-
Shares of Series A preferred stock for cash, net of costs and discounts		118,250			4,186			-		-		-		-		-			-			(9,103	)		(9,103	)
Conversion of Series A preferred shares to common stock		(139,700	)		(22,228	)		-		-		34,253,488		34,253		223,729			-			(117,471	)		140,511
Accrued dividends on Series A preferred stock		-			43,166			-		-		-		-		-			-			(43,166	)		(43,166	)
Cashless exercise of warrants		-			-			-		-		498,260		498		(498	)		-			-			-
Shares of common stock issued for cash, net of offering costs		-			-			-		-		71,100,000		71,100		198,597			-			-			269,697
Shares of common stock issued for compensation		-			-			-		-		1,241,481		1,241		5,209			-			-			6,450
Net loss		-			-			-		-		-		-		-			-			(262,366	)		(262,366	)
Balance, September 30, 2021		296,725		$	127,381			1,500,000	$	1,500		1,393,091,199	$	1,393,091	$	14,305,307		$	-		$	(16,497,964	)	$	(798,066	)

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

F-54 Table of Contents

IGEN NETWORKS CORP.

Condensed Consolidated Interim Statements of Cash Flows

(Unaudited - Expressed in U.S. dollars)

	Nine Months EndedSeptember 30,
	Three Months EndedMarch 31,
	2022			2021
	2023			2022
Cash Flows from Operating Activities
Net loss	$	(~~536~~116,~~615~~809	)	$	(~~940~~186,~~851~~107	)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discounts on convertible debentures		~~35,201~~-			~~103~~25,~~035~~410
Change in fair value of derivative liabilities		(844,~~558~~488	)		(~~156~~39,~~503~~574	)
(Gain) loss on extinguishment of debt		(342,523	)		-
Amortization of right of use asset		6,191			5,551
Amortization of right of use asset		17,162			-
Accrued interest for convertible debt		39,890			5,648
Accrued interest for convertible debt		7,890			-
Stock-based compensation		38,600			13,613
Stock-based compensation		13,613			297,824
Changes in operating assets and liabilities:
Accounts and other receivables		2821,~~271~~270			~~(22~~9,~~825~~068	)
Inventory		23(3,~~036~~725	)		(28117,~~770~~812	)
Prepaid and other assets		-			(5,722	)
Accounts payable and accrued liabilities		(371	)		(15,394	)
Accounts payable and accrued liabilities		9,905			(44,585	)
Deferred revenue		(19,060	)		(3,769	)
Deferred revenue		21,956			11,835
Operating lease liability		(7,848	)		-
Net Cash Used in Operating Activities		(~~730~~86,~~662~~350	)		(~~786~~303,~~562~~366	)
Cash Flows from Financing Activities
Repayment of notes payable and convertible debentures		~~(112,693~~-	)		(~~123~~26,~~556~~601	)
Repayment of lease liability – operating lease		~~(20,495~~-	)		(6,582	)
Repurchase of Series B preferred stock		(1,250	)
Proceeds from issuance of common stock		31,985			-
Proceeds from issuance of common stock		89,240			544,154
Proceeds from notes payable and convertible debentures, net		-			200,000
Proceeds from notes payable and convertible debentures, net		485,000			-
Proceeds from issuance of preferred stock, net		54,365			107,500
Proceeds from issuance of preferred stock, net		310,000			396,749
Net Cash Provided by Financing Activities		86,350			274,317
Net Cash Provided by Financing Activities		749,802			817,347
Change in Cash		-			(29,049	)
Change in Cash		19,140			30,785
Cash, Beginning of Period		-			64,429
Cash, Beginning of Period		64,429			26,731
Cash, End of Period	$	-		$	35,380
Cash, End of Period	$	83,569		$	57,516
Non-cash Investing and Financing Activities:
Conversion of notes payable and accrued interest:
Fair value of common shares issued	$	-		$	18,610
Derecognition of notes payable and accrued interest	$	-		$	(9,616	)
Derecognition of unamortized discount	$	-		$	-
Derecognition of derivative liabilities	$	-		$	(8,994	)
Conversion of preferred stock
Fair value of common shares issued	$	~~464~~123,~~572~~286		$	~~560~~168,~~597~~127
Derecognition of preferred stock	$	(~~300~~82,~~889~~290	)	$	(~~293~~112,~~057~~529	)
Derecognition of unamortized discount	$	~~(100~~19,~~623~~313	)	$	~~157~~63,~~833~~136
Derecognition of derivative liabilities	$	(~~165~~44,~~206~~161	)	$	(~~234~~49,~~443~~876	)
Deemed dividend	$	(9727,~~773~~607	)	$	(~~196~~68,~~787~~857	)
Discount related to issuance of preferred stock	$	~~140~~54,~~152~~395		$	~~294~~57,~~499~~218
Deemed dividends on preferred stock (excluding conversions)	$	~~(96~~11,~~459~~706	)	$	~~(89~~27,~~144~~473	)
Issuance of conversion shares for commitment fee on equity line	$	12,500		$	5,479

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

F-65 Table of Contents

IGEN NETWORKS CORP.

Notes to the Condensed Consolidated Interim Financial Statements

~~September~~March 3031, ~~2022~~2023

(Unaudited - Expressed in U.S. dollars)

1. Organization and Description of Business

IGEN Networks Corp. (“IGEN”, the “Company”, “we”, “our”) was incorporated in the State of Nevada on November 14, 2006, under the name of Nurse Solutions Inc. On September 19, 2008, the Company changed its name to Sync2 Entertainment Corporation and traded under the symbol SYTO. On September 15, 2008, the Company became a reporting issuer in British Columbia, Canada. On May 26, 2009, the Company changed its name to IGEN Networks Corp. On March 25, 2015, the Company was listed on the Canadian Securities Exchange (CSE) under the trading symbol IGN and the Company became a reporting Venture Issuer in British Columbia and Ontario, Canada.

The Company’s principal business is the development and marketing of software ~~services~~solutions for the ~~management and protection of commercial and~~ consumer ~~vehicle~~automotive, ~~assets~~fleet ~~along with driving behavior~~ and ~~profile~~asset ofmanagement ~~these assets~~industries. The ~~software~~consumer ~~services~~solutions are ~~delivered~~marketed ~~from~~through ~~AWS~~credit ~~Cloud~~unions ~~infrastructure~~and ~~over~~financial ~~wireless~~institutions ~~networks~~to mitigate risk and ~~accessed~~provide ~~from~~peace-of-mind ~~mobile~~for orfamily ~~desktop~~driven ~~devices~~vehicles. The ~~software~~commercial ~~services~~brands ~~are~~offer ~~marketed~~robust toand ~~automotive~~patent-protected ~~dealers,~~solutions ~~financial~~for ~~institutions,~~managing ~~governments, and direct~~light-to-~~consumer~~heavy ~~markets~~duty ~~through~~commercial ~~the~~fleets ~~Company’s~~along ~~commercial~~with ~~and~~asset ~~consumer~~management ~~brands~~solutions for improving productivity within supply-chain organizations.

Going Concern

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has experienced recurring losses from operations, has negative operating cash flows since inception, has a working capital deficit of $~~881~~1,~~068~~163,515 and an accumulated deficit of $1920,~~741~~342,~~797~~410 as of ~~September~~March 3031, ~~2022~~2023, and is dependent on its ability to raise capital from stockholders or other sources to sustain operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Ultimately, the Company plans to achieve profitable operations through the increase in revenue base and successfully grow its operations organically or through acquisitions. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

2. Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiary, Nimbo Tracking LLC which is formed in the USA.

The condensed consolidated balance sheet as of December 31, ~~2021~~2022, which has been derived from audited consolidated financial statements, and these unaudited condensed consolidated financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), and include all assets, liabilities, revenues and expenses of the Company and its wholly-owned subsidiary. All material intercompany transactions and balances have been eliminated. These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022. Certain information required by U.S. GAAP has been condensed or omitted in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The results for the three ~~and nine~~ -month ~~periods~~period ended ~~September~~March 3031, ~~2022~~2023 are not necessarily indicative of the results to be expected for the entire fiscal year ending December 31, ~~2022~~2023, or for any future period.

Use of Estimates

The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of stock-based compensation and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

F-76 Table of Contents

Cash and Cash Equivalents

The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents.

Accounts Receivable

Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the allowance for doubtful accounts was approximately $2136,000 and $1116,000, respectively.

Inventory

Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory impairment recorded as of ~~September~~March 3031, 2022 and December 31, 2021.

Equipment

Office equipment, computer equipment, and software are recorded at cost. Depreciation is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, ~~2019~~2022. For purposes of computing depreciation, the method of depreciating equipment is as follows:

Computer equipment	3 years straight-line
Office equipment	5 years straight-line
Software	3 years straight-line

Goodwill

Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually on December 31 of each year or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group.

Goodwill impairment is measured as the amount by which a reporting unit’s carrying value exceeds its fair value.

The Company has only one reporting unit. Therefore, all of the Company’s goodwill relates to that reporting unit, and atas ~~September~~of 30March 31, ~~2022~~2023 and December 31, ~~2021~~2022, the carrying value for that reporting unit is negative.

Impairment of Long-lived Assets

The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs.

F-87 Table of Contents

Financial Instruments

In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

See Note 4 for fair value measurement information related to the Company’s derivative liabilities.

The fair values of cash and cash equivalents, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash and cash equivalents is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash. The Company places its cash and cash equivalents in what it believes to be credit-worthy financial institutions.

Revenue Recognition and Deferred Revenue

We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, using the five-step model, including (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue in accordance with U.S. GAAP. Title and risk of loss generally pass to our customers upon delivery, as we have insurance for lost shipments. In limited circumstances where either title or risk of loss pass upon destination or acceptance or when collection is not reasonably assured, we defer revenue recognition until such events occur. We derive substantially all our revenues from the sale of products and services combined into one performance obligation. Product revenue includes the shipment of product according to the agreement with our customers. Service revenue include vehicle tracking services and customer support (technical support), installations and consulting. A contract usually includes both product and services. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. Performance obligations include, but are not limited to, pass-thru harnesses and vehicle tracking services. Almost all of our revenues are derived from customers located in United States of America in the auto industry. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are not sold on a standalone basis. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue is recognized when our performance obligation has been met. The Company considers control to have transferred upon delivery because the Company has a present right to payment at that time, the Company has transferred use of the asset, and the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. For arrangements under which the Company provides vehicle tracking services, the Company satisfies its performance obligations as those services are performed whereby the customer simultaneously receives and consumes the benefits of such services under the agreement. Revenues are recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.

F-98 Table of Contents

The Company provides product warranties with varying lengths of time and terms. The product warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations. The Company has historically experienced a low rate of product returns under the warranty program.

Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured.

Revenue relating to the sale of service fees on its vehicle tracking and recovery services is recognized over the life of the contact. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable upon delivery of the vehicle tracking devices or in full upon renewal.

Deferred revenues are recorded net of contract assets when cash payments are received from customers in advance of the Company’s performance. Contract assets represent the costs of (1) commission costs, (2) installation costs, and (3) the underlying hardware to enable the Company to perform on its contract with customers and are amortized using the same method and term as deferred revenues. As of September 30, 2022 and December 31, 2021, deferred revenues, net of contract assets totaled $167,441 and $145,485, respectively, and contract assets totaled $141,597 and $71,441, respectively. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as deferred revenue, net of current portion.

During the nine months ended September 30, 2022, the Company recorded additions to deferred revenues of $203,520 and recognized total revenues of $158,017 through the amortization of deferred revenues. During the nine months ended September 30, 2022, the Company recognized revenues of $89,603 related to deferred revenues outstanding as of December 31, 2021 as the services were performed.

Financing Costs and Debt Discount

Financing costs and debt discounts are recorded as reductions to the carrying value of notes payable and convertible debentures. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statement of operations.

Income Taxes

Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Stock-based Compensation

The Company accounts for stock-based payments in accordance with stock-based payment accounting guidance which requires all stock-based payments to be recognized based upon their fair values. The fair value of stock-based awards is estimated at the grant date using the Black-Scholes Option Pricing Model and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. The determination of fair value using the Black-Scholes Option Pricing Model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility, risk-free interest rate, expected dividends and projected employee stock option exercise behaviors. The Company accounts for forfeitures of unvested awards as they occur.

Derivative Financial Instruments

The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.

F-109 Table of Contents

Loss Per Share

Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, the Company has ~~287~~483,~~853~~181,~~408~~298 and ~~259~~442,~~115~~441,~~326~~431 potentially dilutive shares outstanding, respectively.

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, “ ”Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815 - 40)” (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU’s amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements.

3. Convertible Debentures and Notes Payable

On May 17, 2019, the Company entered into a Convertible Promissory Note (“Promissory Note”) with Crown Bridge Partners, LLC (the “Holder”) for a total principal amount of up to $150,000 with cash proceeds of up to $124,500, resulting in an original issue discount of up to $25,500. The Promissory Note bears interest at 7% per annum (with the understanding that the first 12 months of interest of each tranche will be guaranteed). The maturity date is 18 months from the effective date of each payment.

The Conversion Price, as defined in the agreement, is the lesser of (i) the lowest Trading Price (as defined below) during the previous 25 trading day period ending on the latest complete trading day prior to the date of this Promissory Note or (ii) the Variable Conversion Price (as defined below). The Variable Conversion Price means the lowest one Trading Price (as defined below) for the common stock during the 25 Trading Day period ending on the last complete Trading Day prior to the Conversion Date. Trading Price means, for any security as of any date, the lesser of the (i) lowest traded price and (ii) lowest closing bid price. Based on the Company’s examination of the conversion feature and the relative accounting guidance, the Company has determined that the conversion feature should be treated as a derivative liability for accounting purposes.

Additionally, if at any time while the Promissory Note is outstanding, the Conversion Price is equal to or lower than $0.025, then an additional $10,000 will be automatically added to the principal balance of each tranche funded under the Note. During the quarter ended June 30, 2019, $10,000 was added to the principal balance for the first tranche.

In connection with the Promissory Note, the Company also entered into a Securities Purchase Agreement with the Holder which states that the Company will also issue to the Holder a warrant to purchase an amount of shares of its common stock equal to 50% of the face value of each respective tranche divided by $0.10 (for illustrative purposes, the first tranche face value is equal to $50,000, which resulted in the issuance of a warrant to purchase 250,000 shares of the Company’s common stock).

Per the terms of the Common Stock Purchase Warrant agreement, on May 17, 2019, the Company issued a warrant to purchase 250,000 shares of common stock with an Exercise Price of $0.10 subject to adjustment (standard anti-dilution features). The agreement contains a down-round provision that automatically resets the exercise price of the warrant to a new exercise price that is equal to the per share price of common stock subsequently issued (including conversions of debt and preferred stock). Upon the lowing of the exercise price, the number of warrants will be increased such that the total proceeds upon exercise is the same amount (see Note 7). If the Market Price of one shares of common stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares pursuant to cashless exercise, in lieu of cash exercise, per a defined formula in the agreement.

F-1110 Table of Contents

On June 19, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $142,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $122,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. ~~As of September 30, 2022, the principal and interested owed under this note totaled $12,000.~~

On July 10, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $61,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $42,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. ~~As of September 30, 2022, the principal and interested owed under this note totaled $25,000.~~

On May 4, 2020, the Company entered into a Paycheck Protection Program (“PPP”) Loan with a principal amount of $59,949 through a financial institution under the PPP administered by the SBA and established as part of the CARES Act. The PPP Loan bears interest at 1.0% per annum and matures on May 4, 2022 with the first six months of interest and principal payments deferred. The amount borrowed under the PPP Loan is guaranteed by the U.S. Small Business Administration (“SBA”) and is eligible for forgiveness in an amount equal to the sum of the eligible costs, including payroll, benefits, rent and utilities, incurred by the Company during the 24-week period beginning on the date the Company received the proceeds. The PPP Loan contains customary events of default, and the occurrence of an event of default may result in a claim for the immediate repayment of all amounts outstanding under the PPP Loan. As of March 31, 2023, the balance of the PPP Loan, including accrued interest was $61,697.

On July 7, 2020, the Company entered into a secured disaster loan with the SBA with a principal amount of $150,000. The SBA loan bears interest at 3.75% per annum and matures in July 2050. The Company is required to make monthly principal and interest payments of $731 beginning in July 2021. As of March 31, 2023, the balance on the SBA loan, including interest was $165,469.

On November 2, 2020, the Company received $146,500 in net cash proceeds from a note holder under an Inventory Financing Promissory Note. The related principal amount due for the convertible debt instrument was $168,000. The note bears interest at 12% per annum and matures on May 2, 2022. Principal and accrued interest are convertible into common stock at a variable conversion price, which is 80% of the average two lowest traded prices for common stock during a 10-day trading period prior to conversion. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $99,000 and recorded a related derivative liability for that amount. The Company also issued 2,000,000 shares of common stock to the note holder as additional compensation. The value of the shares, ~~was~~ $14,800. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling approximately $135,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. During the nine months ended September 30, 2022, the Company received forgiveness of the note totaling $45,148 and the Company paid down the remaining balance and accrued interest. As of September 30, 2022, the balance on the note is $0.

On December 13, 2021, the Company received $50,000 in net cash proceeds from a note holder under a short-term bridge note. During the nine months ended September 30, 2022, the Company borrowed an additional $85,000 under the note. The Company is required to repay the note and all accrued interest through the maturity date. The note matures on February 13, 2023. As of ~~September~~March 3031, ~~2022~~2023, the balance on the note, ~~including accrued interest~~ was $61160,~~355~~111.

During the nine months ended September 30, 2022, the Company entered into four separate notes with an investor, for total principal of $400,000~~. The notes mature through March 1~~, ~~2023~~ and they bear interest between 6% and 12% per annum. As of ~~September~~March 3031, ~~2022~~2023, the principal and ~~accrued~~ interest owed on these notes ~~total~~totaled $~~401~~410,~~833~~093.

As of ~~September~~March 3031, ~~2022~~2023 long-term debt matures as follows

Year Ending	~~NotesPayable~~Notes Payable		~~ConvertibleNotes~~Convertible Notes		Total
2022 (months remaining)	$	423,297	$	37,000	$	460,296
2023 (months remaining)	$	635,228	$	37,000	$	672,228
2023		111,058		-		111,058
2024		3,454		-		3,454
2025		3,586		-		3,586
2026		3,718		-		3,718
Thereafter		143,686		-		143,686
2027		3,900		-		3,900
	$	688,799	$	37,000	$	725,799
Thereafter		147,484		-		147,484
	$	797,370	$	37,000	$	83,437

4. Derivative Liabilities

During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and during the year ended December 31, ~~2021~~2022, the Company had outstanding convertible debentures with variable exercise prices based on market rates (see Note 3). During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and during year ended December 31, ~~2021~~2022, the Company also issued series A preferred stock with variable exercise prices based on market rates (see Note 6). The Company records the fair value of the conversion features with variable exercise prices based on future market rates in accordance with ASC 815. The fair value of the derivative liabilities is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statements of operations. The Company uses a multi-nominal lattice model to fair value the derivative liabilities. The following inputs and assumptions were used to value the conversion features outstanding during the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, assuming no expected dividends:

	September30, 2022
	March 31, 2023
Expected volatility		135 - 275	%
Risk free interest rate		0.05 – 0.15	%
Expected life (in years)		0 - 1.50

F-1211 Table of Contents

The following table presents the Company’s embedded conversion features of its convertible debt and preferred stock measured at fair value on a recurring basis as of ~~September~~March 3031, ~~2022~~2023.

	Level 3CarryingValue as ofSeptember 30, 2022
	Level 3CarryingValue as ofMarch 31,2023
Derivative liabilities:
Embedded conversion feature - convertible debt	$	-
Embedded conversion feature - preferred stock		~~103~~88,~~290~~462
	$	~~103~~88,~~290~~462

The following table provides a reconciliation of the beginning and ending balances for the Company’s derivative liabilities measured at fair value using Level 3 inputs:

	For TheNine MonthsEndedSeptember 30,2022
	For TheThree MonthsEndedMarch 31,2023
Embedded Conversion Features - Convertible Debt
Balances, as of the beginning of the year	$	~~51,131~~-
Derivative liabilities recorded upon issuance of convertible debt		-
Derivative liabilities derecognized upon debt conversion		-
Net changes in fair value included in net loss		~~(51,131~~-	)
Ending balance	$	-
Embedded Conversion Features - Preferred Stock
Balances, as of the beginning of the year	$	85111,~~771~~010
Derivative liabilities recorded upon issuance of preferred stock		~~140~~66,~~153~~101
Derivative liabilities derecognized upon preferred stock conversion		(~~165~~44,~~206~~161	)
Net changes in fair value included in net loss		(844,~~559~~488	)
Ending balance	$	~~103~~88,~~290~~462
Total ending balance	$	~~103~~88,~~290~~462

5. Related Party Transactions

(a) During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, the Company incurred approximately $~~113~~49,000 and $~~110~~43,000, respectively, in management and consulting fees with an officer and an entity controlled by him. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the Company owed approximately $5,000 ~~and $9,000, respectively,~~ to directors and officers and a company controlled by a director, which is included in accounts payable and accrued liabilities. The amounts owed are unsecured, non-interest bearing, and due on demand. (b) During the nine months ended September 30, 2022 and 2021, the Company incurred approximately $0 and $9,000, respectively, in purchases of hardware from a vendor controlled by a director of the Company. As of September 30, 2022 and December 31, 2021, the amounts owed to this related-party vendor were approximately $0 and $14,000, respectively. (c) During the nine months ended September 30, 2022 and 2021, the Company recorded approximately $0 and $10,000, respectively, to the COO for rent and other office expenses. As of September 30, 2022 and December 31, 2021, the amounts owed to the COO were $0.

F-1312 Table of Contents

6. Redeemable Preferred Stock and Stockholders’ Deficit

Preferred Stock

The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share. The Company has designated 1,250,000 of these shares as Series A Convertible Preferred Stock and 5,000,000 of these shares as Series B Super Voting Preferred Stock.

On February 21, ~~2022~~2023, the Company ~~entered~~issued ~~into~~59,125 ashares of Series A ~~Preferred~~preferred ~~Stock~~stock ~~Purchase Agreement with an investor. The Company issued 59,125 shares~~ for cash proceeds of $5354,~~500~~365.

On March 24, 2022, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,500.

On April 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

On May 20, 2022, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 53,625 shares for proceeds of $48,750.

On August 23, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

On September 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

Rights and Privileges of the Series A Preferred Stock

☐ Voting - Series A Preferred ~~Stock~~Stockholders ~~holders~~ have no voting rights ☐ Dividends - 8% cumulative dividend, compounded daily, payable solely upon redemption, liquidation, or conversion. (increases to 22% for an event of default) ☐ Redemption - Company has the right to redeem the shares from the issuance date through 270 days following the issuance date using the table noted in the Certificate of Designations, Preferences, Rights and Limitations of Series A Convertible Preferred Stock agreement. After 270 days, except for the Mandatory Redemption, the Company does not have the right to redeem the shares. ☐ Mandatory Redemption - 18 months after the Issuance Date or upon the occurrence of an Event of Default, the Company is required to redeem all of the shares of Series A Preferred Stock of the Holder. The Company shall make a cash payment in an amount equal to the total number of shares of Series A Preferred Stock held by the Holder multiplied by the then current Stated Value as adjusted (including but not limited to the addition of any accrued unpaid dividends and the Default Adjustment ☐ Conversion - At any time after 6 months following the Issuance Date, the Holder may convert all or any part of the outstanding Series A Preferred Stock into shares of Common Stock. The Variable Conversion Price is defined as 75% of the the Market Price. The Market Price is defined as the average of the 3 lowest Trading Prices for the Common Stock during the 15 day Trading Period ending on the last complete Trading Day prior to the Conversion Date. ☐ Default Adjustments - Upon the occurrence of any Event of Default, the Stated Value will be increased between 150% and 200%, depending on the Event of Default.

Based on the terms of the conversion feature, the Company could be required to issue an infinite number of shares of common stock. As such, the Company has determined the conversion feature to be a derivative liability under relevant accounting guidance. The Company estimated the fair value of the conversion feature using the Binomial Lattice Model on the date of issuance, on the date of each conversion notice, and remeasures the fair value at each reporting period. During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, the Company issued ~~349~~59,~~250~~125 shares of series A preferred stock for proceeds of $~~317~~54,~~500~~365. Related to these issuances, the Company recorded derivative liabilities of $~~140~~66,~~153~~101 and discounts to the preferred stock of $~~140~~54,~~153~~395, which is being amortized to deemed dividends over the redemption period.

During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, the holder of the series A preferred stock converted ~~299~~79,~~365~~125 shares of series A preferred stock and accrued dividends into ~~132~~88,~~285~~156,~~266~~667 shares of common stock. Related to these conversions during the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, the Company recorded a reduction of the associated derivative liability for the conversion features of $~~165~~44,~~206~~161 and a reduction of the preferred stock discount of $~~100~~19,~~623~~313 and $9716,~~773~~148 of deemed dividend.

F-1413 Table of Contents

Rights and Privileges of the Series B Preferred Stock

In February 2021, the Company issued 500,000 shares, respectively of its Series B Super Voting Preferred Stock. Each share of Series B preferred stock has voting rights equal to 500 shares of common stock, is not entitled to receive dividends, is not convertible into shares of common stock. If the holder of the Series B preferred stock ceases to be a Board Member, the Company will repurchase any Series B preferred stock from the holder for a price of $0.001 per share. If the holder of the Series B preferred stock proposes to transfer any shares of Series B preferred stock, the Company will have 90 days to repurchase the shares for a price of $0.001 per share. The grant date fair value of the Series B preferred stock issued during the ~~nine~~three months ended ~~September~~March 3031, 2021 was $278,447, and was recorded to stock-based director compensation expense in the accompanying condensed consolidated statements of operations.

During the nine months ended September 30, 2022, the Company repurchased 1,250,000 shares of its Series B Super Voting Preferred Stock, valued at $65,572, for $1,250 cash, per the terms of the Series B shareholder agreement.

Common Stock

2023

During the three months ended March 31, 2023, the Company issued 22,000,000 shares of common stock for employee compensation.

During the three months ended March 31, 2023, the Company issued 34,064,050 shares of common stock for cash proceeds of $31,985.

2022

During the ~~nine~~three months ended ~~September~~March 3031, 2022, the Company issued 3,113,005 shares of common stock for services provided by a vendor.

During the ~~nine~~three months ended ~~September~~March 3031, 2022, the Company issued 19,560,705 shares of common stock for the exercise of a warrant on a cashless basis.

During the ~~nine~~three months ended ~~September~~March 3031, 2022, the Company issued ~~132~~37,~~285~~377,~~266~~063 shares of common stock for the conversion of Series A preferred stock and accrued dividends.

During the nine months ended September 30, 2022, the Company issued 12,500,000 shares of common stock as a commitment fee for a new equity line of credit.

During the nine months ended September 30, 2022, the Company issued 42,957,989 shares of common stock for cash proceeds of $89,240.

2021

During the nine months ended September 30, 2021, the Company sold a total of 124,868,383 shares of common stock for proceeds of $544,154.

During the nine months ended September 30, 2021, the Company issued a total of 6,275,537 shares of common stock for the conversion of $60,920 of accrued expenses owed to the VP and General Manager and another employee.

During the nine months ended September 30, 2021, the Company issued 61,996,494 shares of common stock for the conversion of Series A preferred stock and accrued dividends.

During the nine months ended September 30, 2021, the Company issued 1,780,825 shares of common stock for the conversion of debt and accrued interest.

During the nine months ended September 30, 2021, the Company issued a total of 5,977,712 shares of common stock for the cashless exercise of a warrant and a commitment fee.

7. Share Purchase Warrants

The following table summarizes the continuity schedule of the Company’s share purchase warrants:

	Number ofwarrants			Weightedaverageexerciseprice
Balance, December 31, 2021		165,537,526			-
Balance, December 31, 2022		145,079,363			-
Issued		-			-
Adjusted for triggered down-round provisions		-			-
Exercised		~~(20,408,163~~-	)		-
Expired		~~(50,000~~-	)		~~0.20~~-
Balance, September 30, 2022		145,079,363		$	-
Balance, March 31, 2023		145,079,363		$	-

F-1514 Table of Contents

As of ~~September~~March 3031, 2022, the following share purchase warrants were outstanding:

Number of warrants outstanding	Exercise price		Expiration date
2,222,222	$	0.03	December 2, 2024
142,857,141	$	0.00	September 23, 2024
145,079,363

8. Stock Options

The following table summarizes the Company’s stock options:

	Number ofoptions			Weightedaverageexerciseprice		Aggregateintrinsicvalue
Balance, December 31, 2021		3,175,000		$	0.09
Balance, December 31, 2022		1,500,000		$	0.04
Granted		-			-
Exercised		-			-
Cancelled / forfeited		~~(1,425,000~~-	)		~~0.13~~-
Balance, September 30, 2022		1,750,000		$	0.05	$	-
Balance, March 31, 2023		1,500,000		$	0.04	$	-

		Outstanding						Exercisable
Range ofexercise prices		Number ofshares		Weighted averageremainingcontractuallife (years)		Weightedaverageexerciseprice		Number ofshares		Weightedaverageexerciseprice
$	0.04		1,500,000		1.41		0.04		1,500,000		0.04
$	0.08		250,000		0.0		0.08		250,000		0.08
			1,500,000		1.1	$	0.04		1,500,000	$	0.04
			1,750,000		1.4	$	0.05		1,750,000	$	0.05

During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, the Company did not issue any options to employees. During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, the Company recorded $0 of stock-based compensation expense related to stock option grants. As of ~~September~~March 3031, ~~2022~~2023, the Company had no unrecognized compensation expense.

F-1615 Table of Contents

9. Segments

The Company has one reportable segment: vehicle tracking and recovery solutions. The Company allocates resources to and assesses the performance of each reportable segment using information about its revenue and operating income (loss). The Company does not evaluate operating segments using discrete asset information.

Segmentation by geographical location is not presented as all revenues are earned in U.S. Total assets by segment are not presented as that information is not used to allocate resources or assess performance at the segment level and is not reviewed by the Chief Operating Decision Maker of the Company.

10. Risks & Uncertainties

The Company extends credit to customers on an unsecured basis in the normal course of business. The Company’s policy is to perform an analysis of the recoverability of its receivables at the end of each reporting period and to establish allowances where appropriate. The Company analyzes historical bad debts and contract losses, customer concentrations, and customer credit-worthiness when evaluating the adequacy of the allowances.

During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, the Company had ~~four~~ three and two customers which accounted for 8075% and 6789%, respectively, of total invoiced amounts, which are recorded as deferred revenues and amortized over the related service period to revenues.

As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the Company had two and three customers, respectively, which accounted for 9937% and 99%, respectively, of the net accounts receivable balance.

11. Commitments and Contingencies

Indemnities and Guarantees

We have made certain indemnities and guarantees, under which we may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions. We indemnify our officers and directors to the maximum extent permitted under the laws of the State of Nevada. The duration of these indemnities and guarantees varies and, in certain cases, is indefinite. These indemnities and guarantees do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities and guarantees in the accompanying condensed consolidated balance sheets.

Legal Matters

In the ordinary course of business, we may face various claims brought by third parties and may, from time to time, make claims or take legal actions to assert our rights, including intellectual property disputes, contractual disputes and other commercial disputes. Any of these claims could subject us to litigation. Management believes there are currently no claims that are likely to have a material effect on our consolidated financial position and results of operations.

12. Subsequent Events

Through June 8, 2023, the Company issued 104,622,105 shares of common stock related to the conversion of 54,125 shares of Series A preferred stock.

On May 31, 2023, the Company issued a total of 83,333,333 shares of common stock to directors.

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the consolidated financial statements were available for issuance are disclosed as subsequent events, while the consolidated financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

F-1716 Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) provides information for the three ~~and nine~~ month ~~periods~~period ended ~~September~~March 3031, ~~2022~~2023. This MD&A should be read together with our unaudited condensed consolidated interim financial statements and the accompanying notes for the three ~~and nine~~ month ~~periods~~period ended ~~September~~March 3031, ~~2022~~2023 (the “consolidated financial statements”). The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Except where otherwise specifically indicated, all amounts in this MD&A are expressed in United States dollars.

Certain statements in this MD&A constitute forward-looking statements or forward-looking information within the meaning of applicable securities laws. You should carefully read the cautionary note in this MD&A regarding forward-looking statements and should not place undue reliance on any such forward-looking statements. See “Cautionary Note Regarding Forward-Looking Statements”.

Additional information about the Company, including our most recent consolidated financial statements and our Annual Information Form, is available on our website at www.igen-networks.com, or on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

Cautionary Note Regarding Forward-looking Statements

Certain statements and information in this MD&A may not be based on historical facts and may constitute forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws (“forward-looking statements”), including our business outlook for the short and longer term and our strategy, plans and future operating performance. Forward-looking statements are provided to help you understand our views of our short and longer term prospects. We caution you that forward-looking statements may not be appropriate for other purposes. We will not update or revise any forward-looking statements unless we are required to do so by securities laws. Forward-looking statements:

☐

Typically include words and phrases about the future such as “outlook”, “may”, “estimates”, “intends”, “believes”, “plans”, “anticipates” and “expects”;

☐

Are not promises or guarantees of future performance. They represent our current views and may change significantly;

☐

Are based on a number of assumptions, including those listed below, which could prove to be significantly incorrect:

	-	Our ability to find viable companies in which to invest
	-	Our ability successfully manage companies in which we invest
	-	Our ability to successfully raise capital
	-	Our ability to successfully expand and leverage the distribution channels of our portfolio companies;
	-	Our ability to develop new distribution partnerships and channels
	-	Expected tax rates and foreign exchange rates.

☐

Are subject to substantial known and unknown material risks and uncertainties. Many factors could cause our actual results, achievements and developments in our business to differ significantly from those expressed or implied by our forward-looking statements. Actual revenues and growth projections of the Company or companies in which we are invested may be lower than we expect for any reason, including, without limitation:

	-	the continuing uncertain economic conditions
	-	price and product competition
	-	changing product mixes,
	-	the loss of any significant customers,
	-	competition from new or established companies,
	-	higher than expected product, service, or operating costs,
	-	inability to leverage intellectual property rights,
	-	delayed product or service introductions

Investors are cautioned not to place undue reliance on these forward-looking statements. No forward-looking statement is a guarantee of future results.

34 Table of Contents

Overview

During the ~~nine~~three-month ~~months~~period ofended ~~2022~~March 31, 2023, the Company ~~has~~completed ~~made~~its ~~significant~~integration ~~progress~~of oncommercial ~~increasing~~fleet and asset management platforms. In conjunction with its ~~customer~~technology partner Prolog, the Company has developed industry-~~base~~leading solutions for ~~both~~Counties, ~~the~~State ~~consumer~~Governments, and ~~commercial~~Supply-chain ~~platforms~~organizations. ~~The~~ Upon completion of the first deployments to New York State Counties, the Company ~~also~~will ~~increased~~leverage its ~~patent~~County ~~portfolio~~Executives ~~from~~of 20America (“CEA”) endorsement to 40secure ~~claims~~additional deployments across the CEA membership. In addition, the Company’s partnership agreements with certified Credit Union organizations, namely the ~~most~~Association ~~recent~~of ~~patent-pending~~Credit ~~filing~~Union Executives of Puerto Rico (“ASEC”) and Michigan Credit Union League Service Corporation (“MCULSC”) have completed their initial deployments in preparation for ~~scoring~~larger-scale ~~autonomous~~deployments ~~driven~~within ~~vehicles~~their respective regions. ~~Notable~~ Both ~~highlights~~ASEC ofand ~~the~~MCULSC ~~nine-month~~represent ~~period~~approximately ~~ended~~170 ~~September~~Credit ~~30,~~Unions ~~2022~~with ~~include~~over ~~the~~2M ~~following~~active members. The Company ~~achievements:~~has also completed its first phase of due diligence for protecting its patent rights against insurers using driver scores as actuarial metrics for customer billing.

IGEN secures $5M Equity-Line Financing to support product brand growth and strategic initiatives Association of Credit Union Executives of Puerto Rico (ASEC) announces Exclusive Marketing Agreement to sell CU Trak and Family Shield products to its members in Puerto Rico affiliated Latin American territories IGEN files Patent Pending Application for Creating Real-Time Driver Telematic Signatures (DTS) for Autonomous Vehicles IGEN announces Net Profit for Second Quarter 2022 with retirement of debt IGEN launches Medallion GPS PRO for Medium-to-Heavy duty commercial fleets to address the broader needs of government fleets IGEN expands its data infrastructure with AWS to reduce operating costs and extend nationwide disaster recover capabilities IGEN wins award to provide Medallion GPS to New York State Counties IGEN expands hardware offering and transitions to 4G LTE and 5G capabilities CU Track launches roll-out program with Michigan Credit Union League Service Corporation in the Upper Peninsula region Nimbo Tracking secures 11 new franchise and pre-owned dealerships located in 5 states with approximately 2000 vehicles

Financial Condition and Results of Operations

Capital Resources and Liquidity

Current Assets and Liabilities, Working Capital

As of ~~September~~March 3031, ~~2022~~2023, the Company had total current assets of ~~$142~~34,~~199~~498, aan 1834% decrease from December 31, ~~2021~~2022. This ~~increase~~decrease was mostly due to a $2821,~~271~~270 decrease in ~~the Company’s ending~~ accounts receivable ~~balances~~.

The Company’s current liabilities as of ~~September~~March 3031, ~~2022~~2023 were $1,~~023~~198,~~267~~013, a 61% ~~decrease~~increase over those reported as of December 31, ~~2021~~2022. However, $8177,~~380~~495 (or 86%) of the Company’s current liabilities were deferred revenues, net to be recognized in future periods. The ~~decrease~~increase in current liabilities was mostly due to a ~~gain~~$38,484 onincrease ~~the~~in ~~relief of debt for~~ the ~~removal~~current portion of ~~certain old accounts payable balances that are beyond~~ the ~~statute~~notes ~~of limitations~~payable.

As of ~~September~~March 3031, ~~2022~~2023, IGEN had negative working capital of $~~881~~1,~~068~~163,515. Adequate working capital remains a core requirement for growth and profitability and to facilitate further acquisitions, and the Company continues to work at improving its working capital position through ongoing equity and debt financing and actively managing the Company’s growth to achieve sustainable positive cash flow.

During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, the Company raised approximately $~~884~~86,000 in ~~debt~~financings and ~~equity~~converted ~~financings~~approximately $74,000 of preferred stock into shares of common stock. These transactions are further disclosed in notes to the consolidated financial statements.

Total Assets and Liabilities, Net Assets

As of ~~September~~March 3031, ~~2022~~2023, the Company’s total assets were $~~712~~592,~~497~~554, a 64% decrease ~~from~~over December 31, ~~2021~~2022, due primarily to the ~~increase~~decrease in current assets previously discussed. The majority of the Company’s assets remain $505,508 in goodwill associated with the acquisition of Nimbo ~~Tracking~~ LLC in 2014.

As of ~~September~~March 3031, ~~2022~~2023, the Company’s total liabilities were $1,~~409~~445,~~546~~548, which reflects $8666,~~061~~143 in long-term deferred revenue, net in addition to the $1,~~023~~198,~~267~~013 in current liabilities previously discussed. This long-term deferred revenue is the portion of service contracts signed in previous years for which service, and the associated revenue recognition, occurs beyond ~~September~~March 3031, ~~2023~~2024. Total liabilities ~~increased~~decreased by 31% ~~from~~over ~~December~~the ~~31,~~previous ~~2021~~year, however 1210%, or $~~167~~143,~~441~~638 of the Company’s ~~September~~year-end ~~30,~~total ~~2022~~ liabilities was deferred revenue, net, compared with $~~145~~162,~~485~~698 of deferred revenue, net reported as of December 31, ~~2021~~2022.

The above resulted in net assets as of ~~September~~March 3031, ~~2022~~2023 being ($~~597~~(852,~~049~~994) and an accumulated deficit of $19(20,~~741~~342,~~797~~410).

The Company is continuing its efforts to increase its asset base, raise funds and improve cashflow to improve its working capital position. As of the date these financial statements were issued, the Company believes it has adequate working capital and projected net revenues and cash flows to maintain existing operations for approximately six months without requiring additional funding. The Company’s business plan is predicated on raising further capital for the purpose of further investment and acquisition of targeted technologies and companies, to fund growth in these technologies and companies, and to expand sales and distribution channels for companies it currently owns or is invested. It is anticipated the Company will continue to raise additional capital through private placements or other means in the both the near and medium term.

The reader is cautioned that the Company’s belief in the adequacy of its working capital, the continuation and growth of future revenue, the ability of the Company to operate any stated period without additional funding, and the ability to successfully raise capital are forward looking statements for which actual results may vary, to the extent that the company may need capital earlier than anticipated and/or may not be able to raise additional capital.

45 Table of Contents

Results of Operations

Revenues and Net Loss for the Three Months Ended ~~September~~March 3031, ~~2022~~2023

Revenues

For the three months ended ~~September~~March 3031, ~~2022~~2023, the Company had revenues of $~~131~~47,~~575~~216, a ~~125~~2% increase over the revenues reported for same period in ~~2021~~2022. ~~Increase in revenue was primarily due to expanded sales to new automotive dealerships and initial shipments of Medallion GPS to NY State Counties.~~

Costs of goods sold for the three months ended ~~September~~March 3031, ~~2022~~2023 were $~~161~~27,~~249~~250, representing an increase of ~~225~~88% compared to the same period in ~~2021~~2022. These costs are primarily mobile hardware and cellular carrier costs.

The resulting gross profit ~~(loss)~~ percentage was ~~-23~~42% for the three months ended ~~September~~March 3031, ~~2022~~2023 compared to 1569% for the three months ended ~~September~~March 3031, ~~2021.~~2022, ~~The~~representing ~~Company~~a ~~continues~~decrease ~~to examine its costs~~ of ~~delivering~~27% ~~service~~period toon ~~customers and works to limit them as much as possible~~period.

Expenses

Expenses for the three months ended ~~September~~March 3031, ~~2022~~2023, totaled $~~325~~134,~~160~~587, ana ~~increase~~decrease of $5781,~~160~~222, or 2138%, from total expenses reported for the same period in ~~2021~~2022. Due to limited operations, we terminated employees to limit our payroll expenses.

For the three months ended ~~September~~March 3031, ~~2022~~2023, the Company had a net loss ~~available to common stockholders~~ of $~~487~~116,~~188~~809 (or ($(0.00) per basic and diluted share) compared with a net loss of $~~432~~186,~~106~~107 (or ($(0.00) per basic and diluted share) for the same period in 2021. Included in the net loss of $361,060, is $23,161 of other income related to the gain on relief of debt and change in fair value of derivative liabilities recognized during the three months ended September 30, 2022.

The Company will continue to invest in personnel, channels, and product development in order to drive revenue growth and increase gross profits sufficient to enable the Company to achieve profitability.

~~Revenues~~6 ~~and~~Table ~~Net~~of ~~Loss for the Nine Months Ended September 30, 2022~~Contents

Revenues

For the nine months ended September 30, 2022, the Company had revenues of $269,811, a 22% increase over the revenues reported for same period in 2021.

Costs of goods sold for the nine months ended September 30, 2022 were $267,844, representing an increase of 63% compared to the same period in 2021. These costs are primarily mobile hardware and cellular carrier costs.

The resulting gross profit percentage was 1% for the nine months ended September 30, 2022 compared to 26% for the nine months ended September 30, 2021. The difference between period on period gross profit percentage was attributed to the inclusion of infrastructure service costs for the nine months ended September 30, 2022.

Expenses

Expenses for the nine months ended September 30, 2022, totaled $768,835, a decrease of $261,986, or 25%, from total expenses reported for the same period in 2021. Excluding stock-based compensation expense, operational expenses increased by 4% year on year as the result cost cutting measures.

For the nine months ended September 30, 2022, the Company had a net loss attributable to common stockholders of $665,275 (or ($0.00) per basic and diluted share) compared with a net loss attributable to common stockholders of $1,312,777 (or ($0.00) per basic and diluted share) for the same period in 2021. Included in the net loss of $536,615, is $315,880 of other income related to the gain on relief of debt and change in fair value of derivative liabilities recognized during the three months ended September 30, 2022.

5 Table of Contents

Cash Flows and Cash Position

For the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, the Company saw a net ~~increase~~decrease in cash of $~~19,140~~0. Cash used in operating activities was $~~730~~86,~~662~~350, a decrease of 772% from the $~~786~~303,~~562~~366 net cash used for the same period in ~~2021~~2022. This was offset by net financings of $~~884~~86,~~240,~~350 ~~not including repayments of debt of $112,693,~~ raised via private placements. Cash as of ~~September~~March 3031, ~~2022~~2023 was $~~83,569~~0.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

As a smaller reporting company, the Company is not required to provide the information required by this item.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

The Company carried out an evaluation, with the participation of all the Company’s officers, of the effectiveness of the Company’s disclosure controls and procedures as of ~~September~~March 3031, ~~2022~~2023. The conclusions of the Company’s principal officers was that the controls and procedures in place were not effective such that, the information required to be disclosed in our exchange and commission reports was a) recorded, processed, summarized and reported within the time periods specified in the appropriate exchange and commission rules and forms, and b) accumulated and communicated to our management, including our chief executive offer and chief operating officer, as appropriate to allow timely decisions regarding required disclosure.

Internal Control over Financial Reporting

As of ~~September~~March 3031, ~~2022~~2023, management assessed the effectiveness of our internal control over financial reporting. The Company’s management is responsible for establishing and maintain adequate internal control over financial reporting for the Company. Internal control over financial reporting is a set of processes designed by or under the supervision of the Company’s CEO, COO and CFO (or executives performing equivalent functions) to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes those policies and procedures that:

·	pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of our assets;

·	provide reasonable assurance our transactions are recorded as necessary to permit preparation of our financial statements in accordance with GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors;

·	provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. In evaluating the effectiveness of our internal control over financial reporting, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control – Integrated Framework (2013). Based on that evaluation, they concluded that during the period covered by this report, though there are weaknesses in the Company’s internal controls, given the current size of the organization, such internal controls and procedures as were in place were adequately effective to detect the inappropriate application of US GAAP. We did not identify any material weaknesses.

67 Table of Contents

Part II

OTHER INFORMATION

Item 1. Legal Proceedings

No items noted.

Item 1A. Risk Factors.

As a smaller reporting company, the Company is not required to provide the information required by this item, however for a discussion of risk factors affecting the Company please refer to the Cautionary Note Regarding Forward-looking Statements included in Part I Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, the Company issued 322,~~113~~000,~~005~~000 shares of common stock for ~~services~~employee ~~provided by a vendor~~compensation.

During the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, the Company issued 1934,~~560~~064,~~705~~050 shares of common stock for ~~the~~cash ~~exercise~~proceeds of ~~a warrant on a cashless basis~~$31,985.

~~During~~On ~~the~~February ~~nine months ended September 30~~1, ~~2022~~2023, the Company issued ~~132~~59,~~285,266~~125 shares of ~~common stock for the conversion of~~ Series A preferred stock ~~and~~for ~~accrued~~proceeds ~~dividends~~of $54,365.

During the nine months ended September 30, 2022, the Company issued 12,500,000 shares of common stock as a commitment fee for a new equity line of credit.

During the nine months ended September 30, 2022, the Company issued 42,957,989 shares of common stock for cash proceeds of $89,240.

On February 2, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

On March 24, 2022, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 59,125 shares for proceeds of $53,500.

On April 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

On May 20, 2022, the Company entered into a Series A Preferred Stock Purchase Agreements with an investor. The Company issued 53,625 shares for proceeds of $48,750.

On August 23, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

On September 26, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 59,125 shares for proceeds of $53,500.

Item 3. Defaults Upon Senior Securities.

There has been no material default in the payment of any element of indebtedness of the Company. The Company has no preferred stock for which dividends are paid, hence no related arrearage or delinquencies in payments of dividends.

Item 4. Mine Safety Disclosures.

The Company is not an operator, nor has a subsidiary that is an operator, of a coal or other mine.

Item 5. Other Information.

During the period covered by this report there was no information, required to be disclosed in a report on Form 8-K, that was not reported.

During the period covered by this report there were no material changes to the procedures by which security holders may recommend nominees to the registrant’s board of directors.

78 Table of Contents

Item 6. Exhibits.

Exhibit		Index
31.1		Certification - Rule 13(a)-14(a)/15d-14(a) - CEO
32.1		Certification - Section 1350 - CEO
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

89 Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IGEN Networks Corp
November 2, 2022	By:	/s/ Neil Chan
June 9, 2023	By:	/s/ Neil Chan
		Neil Chan
		Chief Executive Officer and Director
		(Principal Executive Officer, Principal Financing
		Officer and Principal Accounting Officer)

910

Filing Compare · IGEN NETWORKS CORP